Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Guillon

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Pharmaceutics|April 27, 2024
Optimizing Nanosuspension Drug Release and Wound Healing Using a Design of Experiments Approach: Improving the Drug Delivery Potential of NDH-4338 for Treating Chemical BurnsTomas L Roldan, Shike Li, Christophe Guillon, et al.
Proteins|December 25, 2009
UV and X-ray structural studies of a 101-residue long Tat protein from a HIV-1 primary isolate and of its mutated, detoxified, vaccine candidateMarine Foucault, Katia Mayol, Véronique Receveur-Bréchot, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
Peripheral site acetylcholinesterase inhibitors targeting both inflammation and cholinergic dysfunctionSherri Young, Karine Fabio, Christophe Guillon, et al.
International Journal of Molecular Sciences|November 26, 2022
The HIV-1 Integrase C-Terminal Domain Induces TAR RNA Structural Changes Promoting Tat BindingCecilia Rocchi, Camille Louvat, Adriana Erica Miele, et al.
European Journal of Immunology|April 12, 2020
Impact of IgA isoforms on their ability to activate dendritic cells and to prime T cellsRémi Gayet, Eva Michaud, Francesco Nicoli, et al.
European Journal of Immunology|September 11, 2002
Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytesCarel A van Baalen, Christophe Guillon, Minus van Baalen, et al.
BMC Pharmacology & Toxicology|June 28, 2022
Identification of 2-(4-N,N-Dimethylaminophenyl)-5-methyl-1-phenethyl-1H-benzimidazole targeting HIV-1 CA capsid protein and inhibiting HIV-1 replication in celluloGuzmán Alvarez, Lisa van Pul, Xavier Robert, et al.
Bioorganic & Medicinal Chemistry|January 18, 2012
Synthesis and evaluation of potent and selective human V1a receptor antagonists as potential ligands for PET or SPECT imagingKarine Fabio, Christophe Guillon, Carl J Lacey, et al.
Recent Patents on CNS Drug Discovery|June 10, 2008
Vasopressin antagonists as anxiolytics and antidepressants: recent developmentsNeal G Simon, Christophe Guillon, Karine Fabio, et al.
DNA and Cell Biology|October 25, 2002
Evaluation in rhesus macaques of Tat and rev-targeted immunization as a preventive vaccine against mucosal challenge with SHIV-BX08Bernard Verrier, Roger Le Grand, Yasemin Ataman-Onal, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Pharmaceutics|April 27, 2024
Optimizing Nanosuspension Drug Release and Wound Healing Using a Design of Experiments Approach: Improving the Drug Delivery Potential of NDH-4338 for Treating Chemical BurnsTomas L Roldan, Shike Li, Christophe Guillon, et al.
Proteins|December 25, 2009
UV and X-ray structural studies of a 101-residue long Tat protein from a HIV-1 primary isolate and of its mutated, detoxified, vaccine candidateMarine Foucault, Katia Mayol, Véronique Receveur-Bréchot, et al.
Bioorganic & Medicinal Chemistry Letters|March 30, 2010
Peripheral site acetylcholinesterase inhibitors targeting both inflammation and cholinergic dysfunctionSherri Young, Karine Fabio, Christophe Guillon, et al.
International Journal of Molecular Sciences|November 26, 2022
The HIV-1 Integrase C-Terminal Domain Induces TAR RNA Structural Changes Promoting Tat BindingCecilia Rocchi, Camille Louvat, Adriana Erica Miele, et al.
European Journal of Immunology|April 12, 2020
Impact of IgA isoforms on their ability to activate dendritic cells and to prime T cellsRémi Gayet, Eva Michaud, Francesco Nicoli, et al.
European Journal of Immunology|September 11, 2002
Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytesCarel A van Baalen, Christophe Guillon, Minus van Baalen, et al.
BMC Pharmacology & Toxicology|June 28, 2022
Identification of 2-(4-N,N-Dimethylaminophenyl)-5-methyl-1-phenethyl-1H-benzimidazole targeting HIV-1 CA capsid protein and inhibiting HIV-1 replication in celluloGuzmán Alvarez, Lisa van Pul, Xavier Robert, et al.
Bioorganic & Medicinal Chemistry|January 18, 2012
Synthesis and evaluation of potent and selective human V1a receptor antagonists as potential ligands for PET or SPECT imagingKarine Fabio, Christophe Guillon, Carl J Lacey, et al.
Recent Patents on CNS Drug Discovery|June 10, 2008
Vasopressin antagonists as anxiolytics and antidepressants: recent developmentsNeal G Simon, Christophe Guillon, Karine Fabio, et al.
DNA and Cell Biology|October 25, 2002
Evaluation in rhesus macaques of Tat and rev-targeted immunization as a preventive vaccine against mucosal challenge with SHIV-BX08Bernard Verrier, Roger Le Grand, Yasemin Ataman-Onal, et al.
Pageof 4